Stockscreener 앱 받기
22.10
3.56%
0.76
시장 영업 전:
22.12
0.02
+0.09%
전일 마감가:
$21.34
열려 있는:
$21.77
하루 거래량:
12.37M
Relative Volume:
1.51
시가총액:
$15.37B
수익:
$125.68M
순이익/손실:
$4.81B
주가수익비율:
3.9115
EPS:
5.65
순현금흐름:
$-781.21M
1주 성능:
+5.39%
1개월 성능:
+3.66%
6개월 성능:
+92.68%
1년 성능:
+86.03%
1일 변동 폭
$21.39
$22.45
1주일 범위
$20.14
$22.45
52주 변동 폭
$8.73
$22.45
Roivant Sciences Ltd Stock (ROIV) Company Profile
명칭
Roivant Sciences Ltd
전화
441-295-5950
주소
7TH FLOOR, 50 BROADWAY, LONDON
ROIV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
22.10 | 14.84B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-02 | 개시 | Citigroup | Buy |
| 2025-07-10 | 재개 | Goldman | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2024-01-05 | 개시 | Piper Sandler | Overweight |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-10-17 | 개시 | Guggenheim | Buy |
| 2023-06-08 | 개시 | BofA Securities | Neutral |
| 2022-10-27 | 개시 | JP Morgan | Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2022-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-15 | 개시 | Goldman | Buy |
| 2021-11-08 | 개시 | H.C. Wainwright | Buy |
| 2021-10-28 | 개시 | Citigroup | Buy |
| 2021-10-26 | 개시 | Cowen | Outperform |
| 2021-10-26 | 개시 | Jefferies | Buy |
| 2021-10-26 | 개시 | Truist | Buy |
모두보기
Roivant Sciences Ltd 주식(ROIV)의 최신 뉴스
Immunovant (IMVT) Is Up 14.0% After $550 Million Follow-On Backed By Roivant SciencesWhat's Changed - simplywall.st
Headlands Technologies LLC Increases Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
BlackBarn Capital Partners LP Sells 125,000 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences stock holds Buy rating at Guggenheim after timeline updates By Investing.com - Investing.com South Africa
Massive Stock Acquisition: Roivant Sciences Bets Big on Immunovant - TipRanks
Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 200,000 Shares - MarketBeat
Roivant Sciences Boosts Investor Confidence With Advancements and Financing Moves - StocksToTrade
HC Wainwright & Co. Maintains Roivant Sciences (ROIV) Buy Recommendation - Nasdaq
Roivant Sciences buys Immunovant (IMVT) shares worth $349.9m By Investing.com - Investing.com Canada
Roivant Sciences buys Immunovant (IMVT) shares worth $349.9m - Investing.com
Roivant Sciences Sees Strategic Consolidation with Key Drug Advancements - timothysykes.com
Roivant Sciences Eyes Strategic Growth: Key Analyst Updates and Development Plans - timothysykes.com
Roivant Sciences stock holds Buy rating at Guggenheim after timeline updates - Investing.com Australia
Roivant Sciences (ROIV) president Venker sells $4.17 million in shares By Investing.com - Investing.com Australia
Roivant Sciences (ROIV) president Venker sells $4.17 million in shares - Investing.com
Roivant Updates Investors On Mosliciguat Development Plans - Citeline News & Insights
Why Is Roivant Sciences Stock Gaining Thursday?Roivant Sciences (NASDAQ:ROIV) - Benzinga
Roivant Sciences (NASDAQ:ROIV) Reaches New 52-Week HighHere's Why - MarketBeat
Roivant Sciences (NASDAQ:ROIV) Reaches New 1-Year HighHere's What Happened - MarketBeat
Price-Driven Insight from (ROIV) for Rule-Based Strategy - news.stocktradersdaily.com
Roivant Sciences (ROIV) Stock Surges After 2025 Investor Day: Pipeline Milestones, Cash Runway and Analyst Forecasts - ts2.tech
HighVista Strategies LLC Sells 54,058 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant accelerates timeline for key drug programs, plans multiple launches By Investing.com - Investing.com Australia
Roivant Sciences Ltd Highlights Pipeline Progress at 2025 Investor Day - TradingView — Track All Markets
Roivant highlights continued pipeline progress and outlook for company's next phase of growth at 2025 Investor Day - marketscreener.com
Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day - marketscreener.com
Roivant (Nasdaq: ROIV) outlines 3+ launches as $550M Immunovant deal extends runway - Stock Titan
Marshall Wace LLP Acquires 683,327 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Immunovant Announces Pricing of $550 Million Common Stock Financing - The Manila Times
Immunovant (Nasdaq: IMVT) raises $550M to support potential IMVT-1402 Graves’ launch - Stock Titan
Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investos - marketscreener.com
WINTON GROUP Ltd Has $2.35 Million Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Norges Bank Invests $6.95 Million in Roivant Sciences Ltd. $ROIV - MarketBeat
A former Roivant spinout bets on AI-designed drugs for immune conditions - Yahoo Finance
iSAM Funds UK Ltd Grows Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences stock hits all-time high at $21.36 By Investing.com - Investing.com Canada
Roivant Sciences stock hits all-time high at $21.36 - Investing.com
Roivant Sciences Ltd. $ROIV is SB Investment Advisers UK Ltd.'s 3rd Largest Position - MarketBeat
88,495 Shares in Roivant Sciences Ltd. $ROIV Acquired by Franklin Resources Inc. - MarketBeat
Cash per share of Roivant Sciences Ltd. – MUN:87S - TradingView
Affinity Asset Advisors LLC Purchases 250,000 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Earnings Beat: Why Roivant Sciences Ltd stock could rally in 2025Quarterly Portfolio Report & High Return Trade Guides - moha.gov.vn
Roivant Sciences Ltd. $ROIV Position Increased by Two Seas Capital LP - MarketBeat
Roivant Sciences Ltd. $ROIV Shares Sold by Pertento Partners LLP - MarketBeat
Is Roivant Sciences Ltd. stock safe for conservative investors2025 Winners & Losers & Daily Profit Focused Screening - Newser
Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Why Roivant Sciences Ltd. stock could rally in 2025Dividend Hike & Weekly Breakout Watchlists - Newser
How Roivant Sciences Ltd. (87S) stock compares with market leadersJuly 2025 Trends & Community Verified Trade Signals - Newser
Is Roivant Sciences Ltd. (87S) stock undervalued by metricsWeekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Will Roivant Sciences Ltd. stock recover faster than peers2025 Market Overview & Capital Efficiency Focused Strategies - Newser
Roivant Sciences Ltd (ROIV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):